Mitogen-activated protein kinases in hemostasis and thrombosis.
about
The inhibitory activity of ginsenoside Rp4 in adenosine diphosphate-induced platelet aggregationInhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.Amarogentin, a secoiridoid glycoside, abrogates platelet activation through PLC γ 2-PKC and MAPK pathwaysIL-17A facilitates platelet function through the ERK2 signaling pathway in patients with acute coronary syndromeSphingosine kinase 1 (Sphk1) negatively regulates platelet activation and thrombus formationValproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individualsHyperthermia inhibits platelet hemostatic functions and selectively regulates the release of alpha-granule proteins.IL-17A increases ADP-induced platelet aggregation.The inhibitory mechanism of crude saponin fraction from Korean Red Ginseng in collagen-induced platelet aggregationNovel Antiplatelet Activity of Minocycline Involves Inhibition of MLK3-p38 Mitogen Activated Protein Kinase Axis.Comprehensive Gene expression meta-analysis and integrated bioinformatic approaches reveal shared signatures between thrombosis and myeloproliferative disorders.Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.Live imaging of extracellular signal-regulated kinase and protein kinase A activities during thrombus formation in mice expressing biosensors based on Förster resonance energy transfer.Dual Roles of Quercetin in Platelets: Phosphoinositide-3-Kinase and MAP Kinases Inhibition, and cAMP-Dependent Vasodilator-Stimulated Phosphoprotein StimulationSystems pharmacology exploration of botanic drug pairs reveals the mechanism for treating different diseases.Schisandra chinensis and Morus alba Synergistically Inhibit In Vivo Thrombus Formation and Platelet Aggregation by Impairing the Glycoprotein VI Pathway.Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolismLicochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways.The contribution of zinc to platelet behaviour during haemostasis and thrombosis.Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms.Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets.Inhibition of Collagen-Induced Platelet Aggregation by the Secobutanolide Secolincomolide A from Lindera obtusiloba Blume.A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation.Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.Platelet activation by Streptococcus sanguinis is accompanied by MAP kinase phosphorylation.No renal protection from volatile-anesthetic preconditioning in open heart surgery.Dual role of the p38 MAPK/cPLA2 pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists.Antiplatelet mechanism of an herbal mixture prepared from the extracts of Phyllostachys pubescens leaves and Prunus mume fruits.New Therapeutic Agent against Arterial Thrombosis: An Iridium(III)-Derived Organometallic Compound.Ask1 regulates murine platelet granule secretion, thromboxane A2 generation, and thrombus formation.Antiplatelet activity of chrysin via inhibiting platelet αIIbβ3-mediated signaling pathway.Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation.Platelet procoagulant phenotype is modulated by a p38 - MK2 axis regulating RTN4/Nogo proximal to the endoplasmic reticulum: utility of pathway analysis.Aged garlic extract suppresses platelet aggregation by changing the functional property of platelets.Effect of Antrodia camphorata on inflammatory arterial thrombosis-mediated platelet activation: the pivotal role of protein kinase C.Cell Type-Specific Mechanisms in the Pathogenesis of Ischemic Stroke: The Role of Apoptosis Signal-Regulating Kinase 1.A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP.Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation.
P2860
Q28817701-BF42FE06-C196-40A7-A6AE-5B5C41DBD8DCQ30663919-8E3A066D-6A2F-4DAD-98D0-E7528B2A8834Q33608991-B7C67F96-D2CD-4EF0-B35A-E89FD9FDEC34Q34342216-118E5B27-D671-4359-B1B7-3A2424A81DFFQ34519103-09436FF4-7132-4988-B260-160AF759B580Q34652709-0D7834D7-9B19-461C-B07D-11377B435DBAQ35161186-E87CC0E0-BBD8-4055-B05F-A683CB2C9C61Q35238914-1730CA0B-2BD3-4D01-BA15-8DEC1FFCCBB7Q35863108-DC898037-0604-458C-BD4B-727CC0C52DC3Q36043123-5C0D596E-4437-4A1E-9D27-5CA50DE6702CQ36205153-AE3C7D2E-F7F4-46AE-9060-9BF5A8218FE8Q36215337-230BF946-D1E0-4CFC-9B04-0CFF26B5B429Q36252847-37570039-E3DE-4F57-8EF4-8893834C8FC1Q36358170-B453E708-EA00-47C6-BDD6-A8858A83FB68Q36497829-2ACB6134-4C1B-4F3F-984E-7B7AB049580FQ37411758-BE7408A2-D8BE-4940-B6A9-016633E93C11Q37618371-8081257E-FB09-4251-84D5-23970129DFFBQ38525064-100D8727-D870-430E-BB96-BE6C2E4CC538Q38680665-D8244F43-C773-41C6-93EA-3722AC068EF3Q38685836-9457E5AC-D3AA-4E69-AED6-EFADA04C537BQ38783535-B48B59B6-670D-4724-BB13-225C77DAC692Q39857872-7F0478A2-3E82-4BBA-AD85-D75F3D9BFAD3Q41525756-C0963C73-CB2A-4129-8960-865E253E44FCQ41533935-35E8C674-8D94-446D-B7A2-322599B6315DQ42279248-5BF96522-68A8-424C-BBA0-E78E66E0C90BQ42485137-F3A47268-69CF-4969-83C0-89E9FF2FBCE7Q42502743-3F81A17D-CC3C-4051-A3AF-BE1C747F0988Q42663126-F16C8CBA-302F-4949-9356-7852B48EEB8DQ42854205-1C08BE4B-008B-4C9F-9398-A0977AB8CF87Q47113062-923A17AE-2C8B-4067-84C1-3AEFFFB47D3EQ47329894-B16E3915-4A7D-4560-AA27-DDA1AC8BFE2BQ48114163-6BA3DD54-1ABB-4303-8BA6-D518C2F7CB7EQ48811710-4BAE09AD-192B-4B4A-ACDC-5A34ACE5F5E9Q50047897-B354A06D-282F-4F64-B5BA-A5CCA707D616Q50141070-9E54C832-F0EC-4EA8-A83E-A5D3FBDBB88EQ51757844-412509EA-A504-4AC1-A12C-C8A48AB3F9F2Q52980046-31161F44-7DAB-4CF4-8454-E07FBC27D690Q54111091-B747A926-D7D4-45AF-8884-83B1E72066F2Q54569298-951D3655-B513-416E-A798-8F319F399611Q54940505-2895582A-9AC2-4ADF-9EA0-6AE09C1179D5
P2860
Mitogen-activated protein kinases in hemostasis and thrombosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitogen-activated protein kinases in hemostasis and thrombosis.
@en
Mitogen-activated protein kinases in hemostasis and thrombosis.
@nl
type
label
Mitogen-activated protein kinases in hemostasis and thrombosis.
@en
Mitogen-activated protein kinases in hemostasis and thrombosis.
@nl
prefLabel
Mitogen-activated protein kinases in hemostasis and thrombosis.
@en
Mitogen-activated protein kinases in hemostasis and thrombosis.
@nl
P2860
P50
P1476
Mitogen-activated protein kinases in hemostasis and thrombosis
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2008.03169.X
P577
2008-12-01T00:00:00Z